MbrlCatalogueTitleDetail

Do you wish to reserve the book?
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
Journal Article

A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease

2016
Request Book From Autostore and Choose the Collection Method
Overview
Cervical cancer is the most common female malignancy in the developing nations and the third most common cancer in women globally. An effective, inexpensive and self-applied topical treatment would be an ideal solution for treatment of screen-detected, pre-invasive cervical disease in low resource settings. Between 01/03/2013 and 01/08/2013, women attending Kenyatta National Hospital's Family Planning and Gynaecology Outpatients clinics were tested for HIV, HPV (Cervista®) and liquid based cervical cytology (LBC-ThinPrep®). HIV negative women diagnosed as high-risk HPV positive with high grade squamous intraepithelial lesions (HSIL) were examined by colposcopy and given a 2 week course of 1 capsule of Lopimune (CIPLA) twice daily, to be self-applied as a vaginal pessary. Colposcopy, HPV testing and LBC were repeated at 4 and 12 weeks post-start of treatment with a final punch biopsy at 3 months for histology. Primary outcome measures were acceptability of treatment with efficacy as a secondary consideration. A total of 23 women with HSIL were treated with Lopimune during which time no adverse reactions were reported. A maximum concentration of 10 ng/ml of lopinavir was detected in patient plasma 1 week after starting treatment. HPV was no longer detected in 12/23 (52.2%, 95%CI: 30.6-73.2%). Post-treatment cytology at 12 weeks on women with HSIL, showed 14/22 (63.6%, 95%CI: 40.6-82.8%) had no dysplasia and 4/22 (18.2%, 95%CI: 9.9-65.1%) were now low grade demonstrating a combined positive response in 81.8% of women of which 77.8% was confirmed by histology. These data are supported by colposcopic images, which show regression of cervical lesions. These results demonstrate the potential of Lopimune as a self-applied therapy for HPV infection and related cervical lesions. Since there were no serious adverse events or detectable post-treatment morbidity, this study indicates that further trials are clearly justified to define optimal regimes and the overall benefit of this therapy. ISRCTN Registry 48776874.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject

Administration, Intravaginal

/ Adult

/ Antiretroviral drugs

/ Antiviral Agents - therapeutic use

/ Antiviral drugs

/ Biology and Life Sciences

/ Biopsy

/ Cancer

/ Cancer therapies

/ Cellular biology

/ Cervical cancer

/ Cervix

/ Cervix diseases

/ Cervix Uteri - drug effects

/ Cervix Uteri - pathology

/ Cervix Uteri - virology

/ Clinical trials

/ Colposcopy

/ Complications and side effects

/ Cytology

/ Departments

/ Developing countries

/ Dosage and administration

/ Drug Administration Schedule

/ Drug Combinations

/ Drug therapy

/ Dysplasia

/ Family planning

/ Female

/ Genotype

/ Gynecology

/ Health risks

/ Health sciences

/ Histology

/ HIV

/ Hospitals

/ Human immunodeficiency virus

/ Human papillomavirus

/ Humans

/ Infections

/ Invasiveness

/ Kenya

/ Laboratories

/ LDCs

/ Lesions

/ Lopinavir

/ Lopinavir - therapeutic use

/ Malignancy

/ Medical screening

/ Medical treatment

/ Medicine and Health Sciences

/ Molecular Typing

/ Morbidity

/ Mortality

/ Oncology

/ Papillomaviridae - drug effects

/ Papillomaviridae - genetics

/ Papillomaviridae - growth & development

/ Papillomavirus Infections - drug therapy

/ Papillomavirus Infections - pathology

/ Papillomavirus Infections - psychology

/ Papillomavirus Infections - virology

/ Pathology

/ Patient Acceptance of Health Care - psychology

/ Quality

/ Risk factors

/ Ritonavir

/ Ritonavir - therapeutic use

/ Self Administration

/ Severity of Illness Index

/ Squamous Intraepithelial Lesions of the Cervix - drug therapy

/ Squamous Intraepithelial Lesions of the Cervix - pathology

/ Squamous Intraepithelial Lesions of the Cervix - psychology

/ Squamous Intraepithelial Lesions of the Cervix - virology

/ Studies

/ Therapy

/ Treatment Outcome

/ Vagina

/ Womens health